Category:natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Specific Gravity: | 1.19700 to 1.20100 @ 20.00 °C.
|
Pounds per Gallon - (est).: | 9.972 to 10.005
|
Refractive Index: | 1.54300 to 1.54700 @ 20.00 °C.
|
Flash Point: | > 230.00 °F. TCC ( > 110.00 °C. )
|
Soluble in: |
| water, 4.563e+004 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
Preferred SDS: View |
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
Not determined
|
Dermal Toxicity: |
Not determined
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | natural substances and extractives |
Recommendation for 3,4,5-trimethoxybenzyl alcohol usage levels up to: | | not for fragrance use.
|
|
Recommendation for 3,4,5-trimethoxybenzyl alcohol flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| benzenemethanol, 3,4,5-trimethoxy- | (3,4,5- | trimethoxyphenyl)methanol |
Articles:
PubMed:New cytotoxic lignan glycosides from Phyllanthus glaucus. |
PubMed:Bioorganic diversity of rare Coriandrum sativum L. honey: unusual chromatographic profiles containing derivatives of linalool/oxygenated methoxybenzene. |
PubMed:Stability of benzylic-type isothiocyanates in hydrodistillation-mimicking conditions. |
PubMed:Four N(7)-alkoxybenzyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[3,4-b]pyridine-5-spiro-1'-cyclohexane-2',6'-diones: hydrogen-bonded supramolecular structures in zero, one, two or three dimensions. |
PubMed:A blocker of N- and T-type voltage-gated calcium channels attenuates ethanol-induced intoxication, place preference, self-administration, and reinstatement. |
PubMed:Oxidation capacity of laccases and peroxidases as reflected in experiments with methoxy-substituted benzyl alcohols. |
PubMed:Antimalarial agents from plants. III. Trichothecenes from Ficus fistulosa and Rhaphidophora decursiva. |
PubMed:Oxygen transfer reactions. 4. Reaction of high valent oxoruthenium compounds with sulfides. |
PubMed:Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats. |
PubMed:Synthesis and platelet-activating factor (PAF)-antagonistic activities of trisubstituted piperazine derivatives. |
PubMed:Synthesis and platelet-activating factor (PAF)-antagonistic activities of 1,4-disubstituted piperazine derivatives. |
PubMed:Effects of KB-5492, 1-(3,4,5-trimethoxybenzyl)-4-((4-methoxyphenyl)oxycarbonylmethyl) p iperazine monofumarate monohydrate, on gastric lesions and gastric secretion in rats. |
PubMed:Biomimetic oxidation of nonphenolic lignin models by Mn(III): new observations on the oxidizability of guaiacyl and syringyl substructures. |
PubMed:Inhibition of norepinephrine transport and reserpine binding by reserpine derivatives. |
PubMed:The effects of colchicine analogues on the reaction of tubulin with iodo[14C]acetamide and N,N'-ethylenebis(iodoacetamide). |
PubMed:[Bronchodilating action of (--)-1-(3, 4, 5-trimethoxybenzyl)-7-hydroxy-1, 2, 3, 4-tetrahydroisoquinoloine HCl (l-MTI) (author's transl)]. |
PubMed:[Bronchodilating and cardiovascular actions of (-)-1-(3, 4, 5-trimethoxybenzyl)-5, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline hydrochloride (l-DTI) in the anesthetized dog (author's transl)]. |
PubMed:[Vasodilating action of (+/-)-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline (TMI) derivatives (author's transl)]. |
PubMed:[Vasodilator action of (+/-)-1-(3, 4, 5-trimethoxybenzyl)-6-hydroxy-1, 2, 3, 4-tetrahydroisoquinoline hydrochloride (CV-705) in anesthetized dogs (author's transl)]. |
PubMed:Bronchodilating actions of (+/-)-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline (TMI) derivatives in anesthetized cats. |
PubMed:[Studies on tetrahydroisoquinolines. V. Actions of 1-(3, 4, 5-trimethoxybenzyl)-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline HCL (AQ-110) on the guinea-pig papillary muscle]. |
PubMed:[Studies on tetrahydroisoquinoline compounds. (3). Pharmacodynamics of 1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline HC1 (AQ-110)]. |
|